Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Liabilities and Shareholders Equity (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 17.1% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.1 million through Dec 2025, down 6.58% year-over-year, with the annual reading at $7.8 million for FY2025, 17.1% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $7.8 million at Creative Medical Technology Holdings, up from $5.9 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $23.4 million in Q2 2022, with the low at $732309.0 in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $10.2 million, with a median of $9.0 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 3100.04% in 2022, then crashed 44.96% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $11.3 million in 2021, then surged by 70.27% to $19.2 million in 2022, then crashed by 44.15% to $10.7 million in 2023, then plummeted by 37.76% to $6.7 million in 2024, then increased by 17.1% to $7.8 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $7.8 million, $5.9 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.